United States · FDA National Drug Code directory
Clindamycin Palmitate Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62135-926_3e9fcb79-a752-3d33-e063-6394a90a48ea
- Product NDC
- 62135-926
- Form
- GRANULE, FOR SOLUTION
- Composition / generic term
- Clindamycin Palmitate Hydrochloride
- Labeler
- Chartwell RX, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170505
- Source listing expiry
- 20261231
Source-listed ingredients
- CLINDAMYCIN PALMITATE HYDROCHLORIDE — 75 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 mL in 1 BOTTLE (62135-926-01) · 62135-926-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →